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Oxidative modifications to amino acid side chains can change the dissociation pathways of
peptide ions, although these variations are most commonly observed when cysteine and
methionine residues are oxidized. In this work we describe the very noticeable effect that
oxidation of histidine residues can have on the dissociation patterns of peptide ions containing
this residue. A common product ion spectral feature of doubly charged tryptic peptides is
enhanced cleavage at the C-terminal side of histidine residues. This preferential cleavage arises
as a result of the unique acid/base character of the imidazole side chain that initiates cleavage
of a proximal peptide bond for ions in which the number of protons does not exceed the
number of basic residues. We demonstrate here that this enhanced cleavage is eliminated
when histidine is oxidized to 2-oxo-histidine because the proton affinity and nucleophilicity of
the imidazole side chain are lowered. Furthermore, we find that oxidation of histidine to
2-oxo-histidine can cause the misassignment of oxidized residues when more than one
oxidized isomer is simultaneously subjected to tandem mass spectrometry (MS/MS). These
spectral misinterpretations can usually be avoided by using multiple stages of MS/MS (MSn)
or by specially optimized liquid chromatographic separation conditions. When these ap-
proaches are not accessible or do not work, N-terminal derivatization with sulfobenzoic acid
avoids the problem of mistakenly assigning oxidized residues. (J Am Soc Mass Spectrom
2007, 18, 553–562) © 2007 American Society for Mass SpectrometryMass spectrometry (MS) is a powerful methodfor identifying amino acid modifications topeptides and proteins. Such identifications are
important in studies of protein post-translational mod-
ifications and in techniques that use covalent labeling to
study protein structure. An emerging set of methods in
the latter category are techniques that rely on oxidative
modifications as indicators of protein structure. These
methods use radicals (such as ·OH) to modify solvent-
exposed [1–10] or metal-bound amino acids [11–18].
Tandem MS (MS/MS), typically in conjunction with
proteolytic digestion, is then used to identify oxida-
tively modified residues and information about protein
structure is then derived. A modified amino acid is
determined by finding product ions whose m/z ratios
are shifted from expected values.
Although oxidative modifications often do not
change peptide ion dissociation patterns, there are
several examples in which they do. Oxidative modifi-
cations to cysteine and methionine residues have very
noticeable effects on peptide ion dissociation patterns.
For example, oxidation of cysteine to cysteic acid in
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doi:10.1016/j.jasms.2006.11.001some cases can lead to very selective peptide dissocia-
tion and in other cases to more efficient overall peptide
dissociation [19–22]. The strong acid character of cysteic
acid enhances peptide bond dissociation at its C-termi-
nal side and can allow mobilization of an additional
proton that initiates cleavages more efficiently at other
peptide bonds as well. Oxidation of cysteine to cysteine
sulfinic acid also leads to selective dissociation on the
C-terminal side of this residue when the peptide charge
state does not exceed the number of arginine residues in
the peptide [23, 24]. Methionine oxidation to methio-
nine sulfoxide can also have a dramatic effect on
peptide ion dissociation patterns [25–29]. When the
number of protons on the peptide does not exceed the
number of basic residues, product ion spectra of pep-
tides containing methionine sulfoxide are dominated by
a neutral loss of methane sulfenic acid (CH3SOH) [29].
Indeed, in many cases no other sequence information is
present, highlighting the effect that this oxidative mod-
ification can have.
Whereas cysteine and methionine residues are
readily oxidized, other amino acids such as those with
aromatic side chains are also susceptible to oxidation
[30], and oxidation of some of these residues might
affect peptide ion dissociation patterns. During our
work with oxidized peptides, we have observed that
oxidation of histidine to 2-oxo-histidine can change
peptide dissociation patterns in very noticeable ways.
Understanding the effect of this oxidative modification
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correctly interpreting tandem mass spectra of peptide
ions containing this residue. In general, histidine oxida-
tion is not only important for methods that rely on
oxidative modifications as indicators of protein struc-
ture, but more broadly speaking oxidative modifica-
tions to this residue are commonly found in proteins
from cells that have undergone oxidative stress [31–33].
Indeed, oxidation of histidine to 2-oxo-histidine in
proteins has been suggested as a good marker of
cellular oxidative stress [34]. Thus, any studies that use
MS to understand protein modifications associated
with oxidative stress are likely to analyze peptides and
proteins with 2-oxo-histidine. In this work we describe
the effect that this oxidative modification to histidine
can have on the dissociation patterns of peptide ions,
attempt to understand its cause, and suggest a means of
avoiding spectral misinterpretations that are possible
when this modification is present in peptides.
Experimental
Materials
Hydrogen peroxide (30%), formic acid, tris(hydroxym-
ethyl)-aminomethane (Tris), and tris(hydroxymethyl)
aminomethane hydrochloride (Tris-HCl) were obtained
from EM Science (Gladstone, NJ). Dithiothreitol (DTT),
sodium ascorbate, ascorbic acid, copper (II) sulfate,
3-morpholinopropanesulfonic acid (MOPS), ammo-
nium acetate, triethylamine, and tetrahydrofuran (THF)
were purchased from Sigma–Aldrich (St. Louis, MO).
Acetic acid and HPLC-grade methanol were obtained
from Fisher Scientific (Fair Lawn, NJ). Chymotrypsin
was obtained from Roche Diagnostics (Indianapolis, IN)
and trypsin was obtained from Promega (Madison, WI).
Distilled, deionized water was generated with a Milli-
pore (Burlington, MA) Simplicity 185 water purification
system.
The peptides angiotensin I (DRVYIHPFHL) and an-
giotensin II (DRVYIHPF) were obtained from Sigma.
The prion peptide Ac-PHGGGWGQ-NH2 was a gift
from Prof. Colin Burns of East Carolina University. The
peptides VSGFHPSDIEVDLL and VNHVTLSQPK are
proteolytic fragments of the protein -2-microglobulin
(2m), which was obtained from Research Diagnostics
(Flanders, NJ). To digest -2-microglobulin (2m), a 200
L solution of the protein (10 M) buffered at pH 7.4
with MOPS was mixed with 100 M DTT, 5 g of
chymotrypsin, 5 g of trypsin, and incubated overnight
at 37 °C. The reaction was terminated by changing the
pH of the solution to about 2 by the addition of acetic
acid. The peptide NVMGHNW is a proteolytic frag-
ment of azurin from Pseudomonas aeruginosa, which was
obtained from Sigma. A 500 L solution of azurin (30
M) at pH 7.4 was digested overnight with 5 g of
trypsin, 5 g of chymotrypsin, and 10 mMDTT at 37 °C.
The reaction was terminated by lowering the pH to
about 2 with acetic acid. The peptide HYGKHHQTY isa proteolytic fragment of Fe-superoxide dismutase (Fe-
SOD), obtained from Sigma. Fe-SOD (30 M) was
digested in the same manner as azurin, but no DTT was
added.
Peptide Oxidation
All the peptides and proteins were oxidized using
metal-catalyzed oxidation (MCO) reactions as described
previously [14, 15, 18]. 2m, azurin, and Fe-SOD were
oxidized at protein concentrations of 20–60 M in
solutions that were buffered with Tris/Tris-HCl or
MOPS at 25–100 mM in open microcentrifuge tubes.
Total sample volumes were 200 L. For 2m, an
equimolar concentration of copper (II) sulfate was
added, whereas azurin and Fe-SOD natively bind Cu
and Fe, respectively, so no metal was added. As we
described previously [14, 15, 18], each of these proteins
is selectively oxidized at the amino acids that bind these
metals. Detailed MCO reaction conditions for 2m [15],
azurin [14], and Fe-SOD [18] can be found in our
previous work. Angiotensin I, angiotensin II, and the
prion peptide were oxidized at concentrations between
100 and 500 M. After adding an equimolar amount of
copper (II) sulfate, the MCO reactions were initiated by
the addition of ascorbate (10 mM), whereas atmospheric
O2 acted as the oxidant. Reactions were stopped by the
addition of 1% (by volume) of glacial acetic acid.
Peptide Derivatization
N-terminal derivatization of the peptides was per-
formed using 2-sulfobenzoic acid anhydride. This an-
hydride was prepared at a concentration of 0.1 M in dry
THF just before use. The peptide solution was diluted
with triethylamine to a final concentration of 50 mM
and an equal volume of the 2-sulfobenzoic acid anhy-
dride solution was added so its final concentration was
50 mM. The mixture was vortexed for 2 min and excess
solvent was evaporated under a stream of N2 gas to
dryness. The sample was redissolved in water and the
peptide was purified using C18 zip-tips.
Instrumentation
All mass spectral analyses were performed on a Bruker
(Billerica, MA) Esquire LC quadrupole ion trap mass
spectrometer. Typically, the needle voltage was kept at
3–4 kV; the capillary temperature was set to 250 °C;
10–60 V was applied to skimmer 1; and the capillary
offset voltage was set between 20 and 60 V. For direct
injection experiments the sample was delivered at 1
L/min using a syringe pump. HPLC-MS analyses of
the peptides were conducted using an HP1100 (Agilent,
Wilmington DE) system with a Zorbax C18 column (4.6
 150 mm; Agilent). The LC effluent was split in a 1:4
ratio with the smaller outlet being fed into the electro-
spray ionization (ESI) source of the quadrupole ion trap
mass spectrometer. For separation of the oxidized an-
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used. The two mobile phases that were used were (A)
water with 0.1% formic acid and (B) a 57/38/5 mixture
of methanol/water/acetonitrile with 0.1% formic acid.
During the separation of the oxidized angiotensin I
isomers, the following percentage increases of mobile
phase B were made: 0–4 min, 10–50%; 4–10 min,
50–70%; 10–30 min, 70–90%; 30–31 min, 90–100%. For
separation of the oxidized prion peptide isomers, the
same mobile phases were used, but the percentage
increases of mobile phase B were: 0–4 min, hold at 10%;
4–6 min, 10–30%; 6–26 min, hold at 30%; 26–28 min,
30–100%.
Results and Discussion
Oxidation Eliminates Preferential Cleavages
at Histidine Residues
Peptide ions containing fewer protons than basic resi-
dues often dissociate preferentially at the C-terminal
side of histidine. This effect is especially notable in the
product ion spectra of doubly protonated peptides
containing a single arginine residue [35, 36]. Both ex-
perimental and theoretical studies have shown that this
enhanced dissociation is initiated by proton transfer
from the side chain of histidine to an adjacent carbonyl
and the subsequent formation of a stable bicyclic struc-
ture [37–40]. Because of its relatively high proton affin-
ity, histidine is protonated typically in tryptic peptide
ions, but having a lower proton affinity than arginine, it
can readily transfer its proton. An enhanced dissocia-
tion pathway is observed when the nucleophilic imino
nitrogen of histidine’s side chain attacks the electro-
philic carbonyl produced after proton transfer (Scheme
1). The b-type product ion that is formed does not have
the typical oxazolone structure but rather has the afore-
mentioned bicyclic structure involving the imidazole
ring of histidine.
When the side chain of histidine is modified by the
net addition of one oxygen atom (16 Da), the prefer-
ential cleavage at the C-terminal side of histidine is no
longer prominent. Figure 1 shows the tandem mass
spectrum of doubly protonated angiotensin I
(DRVYIHPFHL). The product ion spectrum of the un-
oxidized ion (Figure 1a) has several predominant ions,
including y2, y4, b6, b8, b9
2, and y9
2. The y4, b6, and
b9
2 ions arise from peptide bond cleavage on the
C-terminal side of His6 or His9. When angiotensin I is
oxidized at His9, the resulting product ion spectrum of
the doubly protonated parent ion is notably different
(Figure 1b). One prominent difference is the reduction
in the abundance of the b9
2 ion in Figure 1b. Oxidation
of His9 eliminates the enhanced cleavage at the C-
terminal side of this residue. Presumably, the mecha-
nism shown in Scheme 1 occurs less readily when
histidine is oxidized. Interestingly, the enhanced cleav-
age at the C-terminal side of His6 is still observed
because this residue is unmodified and, in fact, theb6/y4 pair is now clearly the dominant dissociation
pathway. Two other results are noteworthy about the
product ion spectrum in Figure 1b. First, the relative
abundance of the y9
2 product ion is reduced and,
second, the relative abundances of the b8 and y2 product
ions are significantly reduced. The reason for the de-
creased abundance of the y9
2 product ion is unclear.
The reduced abundances of the b8 and y2 product ions,
however, are probably attributable to oxidized His9 no
longer being protonated in the low-energy structures of
the (M  2H)2 ion of angiotensin I, which makes
proton transfer to the adjacent peptide bond and for-
mation of the b8 ion less likely. We further consider this
idea below. An additional factor contributing to the
reduced abundance of the b8 ion is the reduced abun-
dance of the b9
2 ion. MS3 data indicate that the b8 ion
is the dominant product ion formed upon dissociation
of the b9
2 ion (data not shown). Thus, very likely some
fraction of the b8 ions is produced normally by a
secondary dissociation of the b9
2 ion and, as the b9
2
pathway becomes less prevalent, so does the abundance
of the b8 ion (Figure 1b).
Another example of the effect of oxidized histidine
on peptide dissociation patterns is found in the product
ion spectrum of His6-oxidized angiotensin I (Figure 1c).
The b6 and y4 product ions are no longer the dominant
Scheme 1. Proposed mechanism [40] for the preferential for-
mation of b ions on the C-terminal side of histidine residuesproducts in the tandem mass spectrum of this ion.
separating them by HPLC.
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2 ions are the most
abundant product ions. Decreased b6 and y4 ion abun-
dances are likely caused by oxidation at His6, which
presumably hinders the dissociation pathway shown in
Scheme 1. Because His6 is oxidized but His9 is not, one
might expect the b9
2 ion to be the most abundant
product ion in Figure 1c because it can be formed
preferentially by the reaction in Scheme 1. Clearly, the
relative ion abundance of b9
2 is greater in Figure 1c
than that in Figure 1b, although its abundance is not as
high as might be expected for a preferential dissociation
pathway. Two other pieces of evidence, though, indi-
cate that it is a preferred dissociation pathway. First, at
the onset of peptide dissociation, the b9
2 is the first
product ion observed and, second, MS3 experiments
indicate that this ion readily dissociates to some of the
other prominent product ions in this spectrum (Figure
1c), including the b8, a8, and a9
2 product ions (data not
shown). Indeed, perhaps the vast difference in ion
abundances between the complementary b8 and y2
product ions in Figure 1c may be an indicator that the
b9
2 ion readily undergoes a secondary dissociation to
form the b8 ion. If the b8 product ion were formed
predominantly by direct dissociation from the parent
ion, then one might expect the ion abundances of the b8
and y2 products to be comparable. Because the ion
abundances are not comparable, the b8 product ion
probably arises mainly by dissociation from the b9
2
ion. In this case, the complementary ion should be a
histidine-containing ion at m/z 138, which is below the
low m/z cutoff used for these MS/MS experiments.
The effect of histidine oxidation on the dissociation
patterns of peptides appears to be a fairly general one
when the number of basic residues (such as Arg, Lys,
His) is equal to or greater than the number of protons.
We have found that the enhanced dissociation adjacent
to histidine is muted to varying degrees in several other
peptides in which histidine residues are oxidized. These
peptides include VSGFHPSDIEVDLL, HYGKHHQTY,
DRVYIHPF, VNHVTLSQPK, and NVMGHNW.
This reduced preference to dissociate at peptide
bonds adjacent to oxidized histidine residues is partly
caused by an oxidation-induced decrease in the proton
affinity of oxidized histidine. Several previous studies
indicate that by far the most common 16 Da product
formed when histidine is oxidized is 2-oxo-histidine
(Scheme 2) [13, 34, 41–45]. Although our MS/MS data
are unable to confirm the exact nature of the modifica-
tion, our results are consistent with the modification
shown in Scheme 2. The proton affinity of 2-oxo-
imidazole, which is the side-chain analog of 2-oxo-
histidine, likely has a lower proton affinity than that of
imidazole, which has a proton affinity of 942.8 kJ/mol
[46]. To our knowledge no measurements of the proton
affinity of 2-oxo-imidazole have ever been made, but its
value is probably similar to the proton affinity of
N,N=-dimethylurea, which is structurally very similar
(Scheme 2) and has a proton affinity of 903.3 kJ/molFigure 1. (a) Product ion spectrum of the unoxidized angiotensin
I (M  2H)2. (b) Product ion spectrum of the His9-oxidized
angiotensin I (M  O  2H)2. (c) Product ion spectrum of the
His6-oxidized angiotensin I (M  O  2H)2. The individual
oxidized His6 and oxidized His9 isomers were obtained by[46]. Furthermore, 2-oxo-histidine is less basic than
557J Am Soc Mass Spectrom 2007, 18, 553–562 Histidine Oxidation Affects Peptide Ion Dissociationhistidine in solution [41]. Thus, histidine oxidation
makes protonation of its side chain less favorable and
subsequent proton transfer to the adjacent amide bond,
as shown in Scheme 1, much less prominent, especially
in peptides that have other reasonably basic sites (such
as other unoxidized histidines as in angiotensin I). This
lower proton affinity explains, in part, the reduced
prominence of the C-terminal cleavages adjacent to
oxidized His6 and His9 (Figure 1), but it also likely
explains the reduced abundances of the b8 and y2 ions
in the product ion spectrum of His9-oxidized angioten-
sin I. These relatively prominent ions in the product ion
spectrum of unoxidized angiotensin (Figure 1a) may
arise from the ability of a proton to be mobilized readily
from the side chain of His9 to the amide bond on the
N-terminal side of this residue. Upon oxidation, His9’s
proton affinity is lowered, and the b8/y2 formation
consequently becomes less prominent.
As indicated above, the reduced proton affinity of
oxidized histidine only partly explains elimination of
the preferential cleavage on the C-terminal side of
histidine residues. In some peptides oxidized histidine
will remain one of the more basic sites and therefore a
likely site of protonation. In these cases, the side-chain
oxidation reduces the preferential cleavage by hinder-
ing the second mechanistic step of the dissociation
pathway shown in Scheme 1 (that is, nucleophilic attack
on the adjacent carbonyl). Undoubtedly, the nucleophi-
licities of the side-chain nitrogens of oxidized histidine
are lower than the nucleophilicity of the imino nitrogen
in unmodified histidine. Thus, even though oxidized
histidine could still be a preferred site of protonation,
formation of the bicyclic structure shown in Scheme 1 is
much less likely. If this is true, then b ions formed from
a cleavage on the C-terminal side of oxidized histidine
will have a different structure than b ions formed from
cleavage on the C-terminal side of unmodified histi-
dine. Instead of the bicyclic structure, the b ions with
oxidized histidine would presumably have the usual
oxazolone structure. One might then expect the disso-
Scheme 2. Structures of 2-oxo-histidine and N,N=-dimethylu-
reaciation patterns of these two different b ions to bedissimilar. Evidence for this contention can be found in
MS3 spectra of angiotensin I. Clearly, the MS3 spectrum
of the unoxidized b6 ion (Figure 2a) is different from the
MS3 spectrum of the b6 ion that has His6 oxidized
(Figure 2b). Two of the more notable differences are the
reduced ion abundances of the a6 and b5 ions in the
spectrum of the oxidized b6 ion. As might be expected,
differences are observed for dissociation pathways that
involve bond-making and bond-breaking steps at posi-
tions close to the site of the structural difference (that is,
a6 and b5 product ions). The MS
3 spectra of the His9-
oxidized and unoxidized b9
2 ions are also very differ-
ent (data not shown), which further supports the notion
that oxidized histidine does not form the bicyclic b ion
as does unmodified histidine.
Mistaken Assignment of Oxidation Sites
The effect of histidine oxidation on peptide dissociation
patterns can have an additional practical implication as
Figure 2. (a) MS3 spectrum of the unoxidized b6 product ion
 3(b ) of angiotensin I. (b) MS spectrum of the oxidized b product6 6
ion (b6  O)
 of angiotensin I.
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more isomers that have different sites of oxidation,
misinterpretation of the MS/MS spectra can occur such
that oxidized residues are inaccurately assigned. Two
examples of this phenomenon are given below.
If the singly oxidized form of angiotensin I is sub-
jected to MS/MS analysis without prior chromato-
graphic separation, the resulting product ion spectrum
can be difficult to interpret correctly (Figure 3). Because
oxidized and unoxidized forms of the y2, y3, y4, b6, b7,
and b8 product ions are observed, one can conclude that
oxidized angiotensin is a mixture of more than one
isomer differing in the site of oxidation. By comparing
the percentages of oxidized forms for each product ion,
observing the absence of unoxidized y5 and b9 ions
(Table 1), and noting the absence of an oxidized b5 ion,
one can further conclude that His6, Pro7, His9, and
possibly Phe8 are oxidized. For example, the y2 and y3
product ions are both about 25 and 15% oxidized,
respectively, whereas the y4 product ion is 90% oxi-
dized. These data suggest that Pro7 is oxidized along
with His9. Similarly, the percentages of oxidized prod-
uct ions in the b series from b6 to b9 suggest that His6,
Pro7, His9, and possibly Phe8 are oxidized. Clearly,
these y- and b-series are inconsistent with respect to
whether Phe8 is oxidized. A series of MSn experiments,
including MSn of the y4  O, (b9  O)
2, and the b8 
O product ions, are required to clarify that Phe8 is not
oxidized (data not shown). Furthermore, MSn data
indicate that Pro7 is also not oxidized and confirm that
oxidation is limited to only His6 and His9. Thus, the
singly oxidized form of angiotensin is really only a
mixture of two isomers. The misleading interpretation
of the MS/MS spectrum in Figure 3 arises because
oxidative modifications at His6 and His9 suppress the
normally prominent dissociation pathways adjacent to
these residues. In the His6-oxidized angiotensin ions,
Figure 3. Product ion spectrum of the singly oxidized angioten-
sin I (M  O  2H)2 after simultaneously subjecting the isomeric
His6- and His9-oxidized forms to CID without prior separation.formation of the b6  O and y4 ions is suppressed,whereas formation of the b8  O and y2 product ions is
relatively unaffected. In contrast, formation of the b8
and y2O ions is suppressed in the His9-oxidized ions,
whereas formation of the b6 and y4  O product ions is
unaffected. These combined effects make it easy to
misinterpret the data in Figure 3.
The product ion spectrum of the singly oxidized
prion peptide (Ac-PHGGGWGQ-NH2) is also difficult
to interpret correctly (Figure 4a). A prominent b-series
is observed and, upon examining the b-series, the
parent ion at m/z 852.4 [M  O  H] appears to be a
mixture of perhaps five isomeric peptides differing by
the site of oxidation. This conclusion arises from the
series of b ions from b2 to b5 that have increasing
percentages of oxidized forms (Table 2). The partial
oxidation (15%) of the b2 product ion indicates that
either proline or histidine is oxidized in some of the
peptides; MS3 data confirm that histidine but not pro-
line is oxidized. Complete oxidation (100%) of the b6 ion
indicates that Gly3, Gly4, Gly5, and/or Trp6 are oxi-
dized. Because the relative oxidation percentages in-
crease along the series b3 to b6, the data suggest that
Gly3, Gly4, Gly5, and Trp6 are all oxidized. This con-
clusion, however, is incorrect. Not only does the lack of
a side chain make it unlikely that any of the glycine
residues are oxidized [30], but MS3 spectra of the b5 
O, b4  O, and b3  O product ions indicate that His2
Table 1. Percentage of oxidized product ions observed
in the tandem mass spectrum of the doubly charged ion
of singly oxidized angiotensin (M  O  2H)2
Product
ion m/zunoxidized
a m/zoxidized
a
Percentage
oxidizedb
y2 269 285 25
y3 416 432 15
y4 513 529 90
y5 649 665 100
c
y6 763 779 100
y7 926 942 100
y8 1025 1041 100
y9
2 591 599 —d
b2 272 288 0
b3 371 387 0
b4 534 550 0
b5 647 663 0
b6 784 800 20
b7 881 897 45
e
b8 1028 1044 80
b9
2 583 591 100
aThese m/z ratios correspond to the nominal m/z ratio of the observed
product ions.
bThe percentage oxidized is obtained by dividing the ion abundance of
the oxidized product ion by the sum of the ion abundances of the
oxidized and unoxidized product ions. The values typically had a
relative standard deviation of about 20%.
cThe ion abundance of the unoxidized y5 product ion is difficult to
accurately determine because of an interfering ion m/z 648.5, which
corresponds to a loss of NH3 from the parent ion. A high resolution
scan, however, suggests that no unoxidized y5 ion atm/z 649 is present.
dThe ion abundance of the unoxidized y9
2 product ion cannot be
determined because it is isobaric with the oxidized b9
2 product ion.
eThe ion abundance of the b7 product ion is very low, which makes
determination of the percentage oxidized difficult.
559J Am Soc Mass Spectrom 2007, 18, 553–562 Histidine Oxidation Affects Peptide Ion Dissociationbut not Gly3, Gly4, or Gly5 is oxidized. Figure 5 is a
representative MS3 spectrum of the b4  O product ion.
The absence of any unoxidized b2 or b3 product ions
and the absence of an oxidized b1 ion demonstrate that
oxidation is limited to His2. Interestingly, b1 ions are
often not observed in the product ion spectra of peptide
ions, but perhaps the acetylated N-terminus allows this
ion to form. An MS3 spectrum of the b6 O product ion
indicates that Trp6 is also oxidized (data not shown).
So, the singly oxidized ion at m/z 852 is only a mixture
of two isomers, one in which His2 is oxidized and
another in which Trp6 is oxidized.
The potentially incorrect interpretation of the prod-
uct ion spectrum in Figure 4a arises because oxidized
histidine hinders the dissociation pathways giving rise
Figure 4. (a) Product ion spectrum of the si
simultaneously subjecting the isomeric oxidized
ion spectrum of the unoxidized prion pepti
His2-oxidized prion peptide (M  O  H). (d
peptide (M  O  H). The individual oxidize
separating them by HPLC.ngly oxidized prion peptide (M  O  H) after
forms to CID without prior separation. (b) Product
de (M  H). (c) Product ion spectrum of the
) Product ion spectrum of the Trp6-oxidized prion
d His2 and oxidized Trp6 isomers were obtained byto the b2  O, b3  O, and b4  O product ions. ThisTable 2. Percentage of oxidized product ions observed
in the tandem mass spectrum of the singly charged ion
of singly oxidized prion peptide (M  O  H)
Product
ion m/zunoxidized
a m/zoxidized
a
Percentage
oxidizedb
b2 277 293 15
b3 334 350 25
b4 391 407 40
b5 448 464 55
a6 606 622 100
b6 634 650 100
b7 691 707 100
aThese m/z ratios correspond to the nominal m/z ratio of the observed
product ions.
bThe percentage oxidized is obtained by dividing the ion abundance of
the oxidized product ion by the sum of the ion abundances of the
oxidized and unoxidized product ions. The values typically had a
relative standard deviation of about 20%.
560 BRIDGEWATER ET AL. J Am Soc Mass Spectrom 2007, 18, 553–562becomes clear when the His2- and Trp6-oxidized forms
of the prion peptide are separated and their product ion
spectra are acquired separately (Figure 4b, c, and d).
Upon comparing the product ion spectrum of the
unmodified (Figure 4b), His2-oxidized (Figure 4c), and
Trp6-oxidized (Figure 4d) forms of the prion peptide,
clearly histidine oxidation essentially eliminates the b2
 O ion channel. Oxidation to His2 also reduces the
abundances of b3  O and b4  O product ions to
differing degrees. The net effect is that when both
oxidized isomers are simultaneously subjected to MS/
MS, as in Figure 4a, incorrect assignment of the oxi-
dized residues is a real possibility.
Avoiding Spectral Misinterpretation
Mistakenly assigning oxidized residues is obviously a
problem, but there are several potential ways to avoid
this situation. Two means are evident from the data
above. Additional stages of MS/MS (or MSn) are capa-
ble of correctly identifying the oxidized residues in
angiotensin I and the prion peptide. Not all mass
spectrometers, however, are as readily able to perform
such MSn experiments as a quadrupole ion trap mass
spectrometer, which was used in these studies. LC
separation of any oxidized peptide isomers before mass
spectral analysis is another approach to avoid compli-
cations associated with simultaneously subjecting two
or more isomers to MS/MS analysis. Indeed, the
MS/MS spectra of the His6- and His9-oxidized forms of
angiotensin (Figure 1) were obtained after LC separa-
tion. Unfortunately, separating these isomers required
significant optimization and LC conditions that are
atypical for normal peptide or protein digest separa-
tions. The ability to separate isomers using LC cannot
be guaranteed for every oxidized peptide, so this ap-
proach to avoiding spectral misinterpretation may not
Figure 5. MS3 spectrum of the oxidized b4 product ion (b4 O)

of the prion peptide.be generally effective. Another way to avoid the effects of histidine oxida-
tion would be to use a dissociation approach that is less
affected by amino acid side-chain chemistry. One such
approach is N-terminal derivatization with sulfonic
acid. Keough and coworkers previously showed that a
simple one-step derivatization with sulfobenzoic acid
cyclic anhydride is a useful approach for de novo
sequencing of a wide range of peptides [47, 48]. When
derivatized with this strong acid, peptide ions have an
additional proton that is readily mobilized along the
backbone to facilitate cleavage at almost all peptide
bonds. We have found that derivatization with this
group can overcome the interpretation difficulties asso-
ciated with dissociating peptide ions with more than
one oxidized isomer. As an example of this approach,
Figure 6 shows the product ion spectrum of the doubly
charged derivatized form of oxidized angiotensin I.
From Figure 6 and the percentages of oxidized product
ions (Table 3), localizing the oxidation to His6 and His9
is more straightforward. The oxidation percentages for
the y2 and y4 product ions are very close and the
oxidation percentages of the b6* and b8* ions are also
very close. The slight differences in oxidation percent-
ages for these product ion pairs could have arisen from
experimental error, a slight effect of oxidation on the
dissociation patterns, or a small percentage of oxidation
actually occurring at Pro7 and/or Phe8. The latter
possibility is ruled out by MS3 data on several of the
product ions in Figure 6, which provide no evidence for
oxidation at Pro7 or Phe8. Also, LC-MS of angiotensin I
after oxidation (inset, Figure 6) provides evidence for
only two singly oxidized forms (that is, [M  O]) of the
peptide.
Figure 6. Product ion spectrum of the derivatized form of
oxidized angiotensin I (M  O  C H SO  2H). All the b ions7 4 4
contain the sulfonic acid group.
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Oxidation of histidine can lead to very noticeable
changes in the dissociation patterns of peptide ions
containing this residue. The preferential cleavage at the
C-terminal side of histidine, which is often observed in
product ion spectra of peptides with basic residues that
equal or exceed the number of protons on the peptide,
is reduced or eliminated upon oxidation of histidine.
This effect is caused by the lower proton affinity and
weaker nucleophilicity of 2-oxo-histidine compared to
that of histidine.
Practically speaking, histidine oxidation can lead to
spectral misinterpretations. This is especially a problem
when an oxidized peptide consists of more than one
isomer differing by the site of oxidation. The use of MSn
and LC-MS/MS can often avoid misassignments of
oxidized residues, but the inability to do MSn on all
mass spectrometers and the special chromatographic
conditions required to separate oxidized isomers limit
the general utility of these approaches. An alternate
solution is to derivatize the N-terminus of the peptide
with sulfobenzoic acid. This derivatization step repre-
sents an easy and general approach to avoid spectral
misinterpretations because this modification reduces
the effect of side-chain chemistry on peptide ion disso-
ciation pathways. We suspect other techniques that are
relatively insensitive to side-chain chemistry, such as
electron-capture dissociation and electron-transfer dis-
sociation, will also be effective at generating product
ion spectra that can be interpreted in a more straight-
Table 3. Percentage of oxidized product ions observed in the
tandem mass spectrum of the doubly charged derivatized ion of
singly oxidized angiotensin (M  O  C7H4SO4  2H)

Product
ion m/zunoxidized
a m/zoxidized
a
Percentage
oxidizedb
y2 269 285 40
y3 416 432 —
c
y4 513 529 45
y5 649 665 100
y6 763 779 100
y7 926 942 100
y8 1025 1041 100
y9
2 591 599 100
b2 456 472 0
b3 555 571 0
b4 718 734 0
b5 831 847 0
b6 968 984 45
b7 1065 1081 —
c
b8 1212 1228 55
b9 1333 1349 100
aThese m/z ratios correspond to the nominal m/z ratio of the observed
product ions.
bThe percentage oxidized is obtained by dividing the ion abundance of
the oxidized product ion by the sum of the ion abundances of the
oxidized and unoxidized product ions. The values typically had a
relative standard deviation of about 20%.
cThe y3 and b7 product ions were not observed.forward manner.Acknowledgments
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